Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04702529 · ClinicalTrials.gov registry record · NA
Treatment of Fibrotic Scars With Rapid Acoustic Pulse (RAP) Device
A NA study, sponsored by Soliton.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04702529 is a NA study that has completed, run by Soliton. The registered enrollment target is 20 participants.
The verdict
NCT04702529, a NA study, has completed, sponsored by Soliton.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
A multi-treatment proof of concept clinical study is to evaluate the safety, and efficacy of multiple treatments with Soliton's Rapid Acoustic Pulse (RAP) device for the improvement in the appearance of fibrotic scars
Interventions
- DEVICE Treatment of hypertrophic scars (Soliton's Rapid Acoustic Pulse (RAP) Device)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-06-22 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04702529
The ClinicalTrials.gov registry entry for NCT04702529 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Soliton, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment of hypertrophic scars (Soliton's Rapid Acoustic Pulse (RAP) Device) is the first listed.
NCT04702529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04702529 about?
NCT04702529 is a clinical study titled "Treatment of Fibrotic Scars With Rapid Acoustic Pulse (RAP) Device". A multi-treatment proof of concept clinical study is to evaluate the safety, and efficacy of multiple treatments with Soliton's Rapid Acoustic Pulse (RAP) device for the improvement in the appearance of fibrotic scars
What is the current status of trial NCT04702529?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-06-22. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT04702529?
The interventions under investigation include: Treatment of hypertrophic scars (Soliton's Rapid Acoustic Pulse (RAP) Device) (DEVICE).
Who is sponsoring clinical trial NCT04702529?
This trial is sponsored by Soliton, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.